ML309 - CAS 1355446-05-7

ML309 is a potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells. ML309 is capable of potent and selective inhibition of mutant IDH1 and effectively lowers cell-based production of 2-HG in a U87MG mutant glioblastoma cell line.

Others

Others

1355446-05-7

C29H29FN4O2

484.56

C(N(C(CN1C=2C(N=C1)=CC=CC2)=O)C3=CC(F)=CC=C3)(C(NC4CCCC4)=O)C5=C(C)C=CC=C5

-20°C

Ice Packs

Small Compound